Showing 5731-5740 of 20433 results for "".
- Weight Management and Fertility Preservation in Endometrial Cancer Patientshttps://reachmd.com/news/weight-management-and-fertility-preservation-in-endometrial-cancer-patients/2475594/A newly developed, evidence-based weight management program is poised to transform care for endometrial cancer patients pursuing fertility preservation. This initiative integrates oncologic treatment with reproductive health strategies, offering a standardized proto
- Revolutionizing Alzheimer's Care with Biomarkers and Nutritionhttps://reachmd.com/news/revolutionizing-alzheimers-care-with-biomarkers-and-nutrition/2475584/In the relentless pursuit of more effective Alzheimer's interventions, emerging evidence places biomarkers and nutrition at the forefront of early detection strategies, challenging clinicians to rethink diagnostic and preventive approaches no
- Glibenclamide's Role in Cerebral Edema Management Post-Strokehttps://reachmd.com/news/glibenclamides-role-in-cerebral-edema-management-post-stroke/2475589/Managing cerebral edema in acute stroke is a significant challenge in optimizing neurological outcomes; preliminary studies indicate that glibenclamide may provide potential benefits, though further research is needed to confirm its efficacy.
- Obinutuzumab Reshapes Lupus Nephritis Managementhttps://reachmd.com/news/obinutuzumab-reshapes-lupus-nephritis-management/2475590/Obinutuzumab is reshaping lupus nephritis management with improved renal outcomes when added to standard regimens, with 46.4% of patients achieving a complete renal response compared to
- Positive Early Results in Tralokinumab Trial for AD on Handshttps://reachmd.com/news/Positive-Early-Results-Tralokinumab-Trial-AD-Hands/2475575/A trial evaluating tralokinumab for the treatment of adults with moderate-to-severe atopic dermatitis (AD) on the hands, who are candidates for systemic therapy, met the primary endpoint and all secondary endpoints with a statistically significant improvement in AD on the hands after 16 weeks of
- Analysis Concludes No Single Preclinical Model Fully Mimics Human PsOhttps://reachmd.com/news/Analysis-Concludes-No-Single-Preclinical-Model-Fully-Mimics-Human-PsO/2475576/Despite extensive preclinical model development, no single system fully mimics human psoriatic disease, according to a new analysis published in Expert Opinion on Drug Discovery. Researchers on the study emphasized the importance of preclinical models that can reproduce disease-re
- RSV Vaccination 2025: Navigating CDC Updates and Addressing Health Disparitieshttps://reachmd.com/news/rsv-vaccination-2025-navigating-cdc-updates-and-addressing-health-disparities/2475559/Infectious disease specialists are adapting to the shifting landscape of RSV vaccination to effectively guide patient care, as recent updates from the CDC redefine age-based eligibility and emphasize addressing health disparities. Spec
- Enhancing Surgical Precision with Augmented Reality and AIhttps://reachmd.com/news/enhancing-surgical-precision-with-augmented-reality-and-ai/2475564/For liver surgeons performing minimally invasive resections and multidisciplinary surgical teams, challenges in tumor visualization and postoperative complications highlight the need for technologies that enhance surgical precision and proact
- Transformative Role of Urine-Based Biomarkers in Early Prostate Cancer Detectionhttps://reachmd.com/news/transformative-role-of-urine-based-biomarkers-in-early-prostate-cancer-detection/2475558/Urologists face a clinical paradox: how to catch prostate malignancies early while sparing patients the pain and complications of invasive procedures. Recent data reveal how the
- Targeting HIV-1 Vpr: Disrupting Viral Replication for New Antiviral Strategieshttps://reachmd.com/news/targeting-hiv-1-vpr-disrupting-viral-replication-for-new-antiviral-strategies/2475569/As HIV-1 continues to challenge global health, new insights into the viral protein R (Vpr) reveal it as a pivotal influencer of replication in T cells and macrophages, posing both challenges and opportunities for treatment advancements. <